Tomasz Domoradzki
Overview
Explore the profile of Tomasz Domoradzki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pajak B, Siwiak-Niedbalska E, Jaskiewicz A, Soltyka M, Domoradzki T
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359318
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults with a poor prognosis. Despite significant progress in drug development, the blood-brain barrier (BBB) continues to limit...
2.
Blaszczyk M, Gajewska M, Dymowska M, Majewska A, Domoradzki T, Prostek A, et al.
Histochem Cell Biol
. 2022 Mar;
157(5):525-546.
PMID: 35230485
Interleukin (IL)-6, a known proinflammatory cytokine, is released in both visceral adipose tissue and contracting skeletal muscle. In this study, we used microRNA profiling as a screening method to identify...
3.
Domoradzki T, Grochowski P, Jaskiewicz A, Pajak B
J Appl Genet
. 2021 Dec;
63(2):305-313.
PMID: 34967917
Our concerns have been raised about whether prolonged exposure to ammunition-related chemicals could correlate with genomic instability predisposing to lung carcinogenesis. The group of professional soldiers engaged in routine ammunition...
4.
Pajak B, Siwiak-Niedbalska E, Jaskiewicz A, Soltyka M, Zielinski R, Domoradzki T, et al.
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944565
Over the last decade, we have seen tremendous progress in research on 2-deoxy-D-glucose (2-DG) and its analogs. Clinical trials of 2-DG have demonstrated the challenges of using 2-DG as a...
5.
Jaskiewicz A, Domoradzki T, Pajak B
Int J Mol Sci
. 2020 Nov;
21(21).
PMID: 33158194
Muscle cachexia is one of the most critical unmet medical needs. Identifying the molecular background of cancer-induced muscle loss revealed a promising possibility of new therapeutic targets and new drug...
6.
Milewska M, Domoradzki T, Majewska A, Blaszczyk M, Gajewska M, Hulanicka M, et al.
Cell Tissue Res
. 2019 Dec;
380(1):155-172.
PMID: 31820147
Interleukin (IL)-6 is a proinflammatory cytokine released in injured and contracting skeletal muscles. In this study, we examined cellular expression of proteins associated with cytoskeleton organization and cell migration, chosen...
7.
Milewska M, Domoradzki T, Majewska A, Blaszczyk M, Gajewska M, Hulanicka M, et al.
J Cell Physiol
. 2019 Apr;
234(11):19675-19690.
PMID: 30945300
Interleukin (IL)-8 is released both in visceral adipose tissue and in contracting skeletal muscles. In this study, we examined cellular pathways associated with muscle hypertrophy, chosen on the basis of...
8.
Majewska A, Domoradzki T, Grzelkowska-Kowalczyk K
Methods Mol Biol
. 2018 Oct;
1889:127-168.
PMID: 30367413
Microarray-based transcriptomic profiling enables simultaneous measurement of expression of multiple genes from one biological sample. Here we describe a detailed protocol, which serves to examine global gene expression using whole...